Diseases
MGUS and smoldering myeloma
4 papers and 8 abstracts co-authored by Raphael E. Szalat. Current lab members are shown in bold.
Papers 4
- 2026
Genomically Smoldering Multiple Myeloma Is Not a Distinct Entity But a Collection of Monoclonal Gammopathy of Undetermined Significance or Multiple Myeloma
- 2022
Prevalence of monoclonal gammopathy of undetermined significance in US black women
- 2021
Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma
- 2018
Genomic patterns of progression in smoldering multiple myeloma
Abstracts & posters 8
- 2024
Differentiating between MM like Smoldering Myeloma (SMM) and Non-Progressor SMM
- 2021
Defining Genomic Probability of Progression to Identify Low-Risk Smoldering Multiple Myeloma
- 2021
OAB-043: Progression and probability of progression are driven by different genomic features in precursor conditions in myeloma
- 2020
High Throughput Genomic Analysis Identifies Low-Risk Smoldering Multiple Myeloma
- 2019
Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study
- 2019
S120 CHRONOLOGY OF COPY NUMBER ALTERATIONS FROM PRECURSORS TO MULTIPLE MYELOMA: WHAT COMES FIRST?
- 2016
The Complex Landscape of Rearrangements in Smoldering and Symptomatic Multiple Myeloma Revealed By Whole-Genome Sequencing
- 2016
Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern